Raymond James Financial Services Advisors Inc. grew its position in shares of Doximity, Inc. (NASDAQ:DOCS – Get Rating) by 23.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 10,733 shares of the company's stock after purchasing an additional 2,004 shares during the quarter. Raymond James Financial Services Advisors Inc.'s holdings in Doximity were worth $324,000 as of its most recent filing with the SEC.
Several other hedge funds also recently modified their holdings of the company. D.A. Davidson & CO. increased its position in shares of Doximity by 2.8% during the 2nd quarter. D.A. Davidson & CO. now owns 10,050 shares of the company's stock valued at $350,000 after purchasing an additional 273 shares during the period. Weiss Multi Strategy Advisers LLC boosted its stake in shares of Doximity by 6.9% during the 1st quarter. Weiss Multi Strategy Advisers LLC now owns 4,810 shares of the company's stock worth $251,000 after acquiring an additional 310 shares in the last quarter. Washington Trust Advisors Inc. boosted its stake in shares of Doximity by 80.1% during the 2nd quarter. Washington Trust Advisors Inc. now owns 962 shares of the company's stock worth $33,000 after acquiring an additional 428 shares in the last quarter. Griffin Asset Management Inc. boosted its stake in shares of Doximity by 4.4% during the 3rd quarter. Griffin Asset Management Inc. now owns 12,970 shares of the company's stock worth $392,000 after acquiring an additional 550 shares in the last quarter. Finally, Beacon Pointe Advisors LLC boosted its stake in shares of Doximity by 2.4% during the 2nd quarter. Beacon Pointe Advisors LLC now owns 23,729 shares of the company's stock worth $825,000 after acquiring an additional 560 shares in the last quarter. 52.48% of the stock is currently owned by institutional investors and hedge funds.
Get Doximity alerts:Doximity Trading Up 4.5 %
DOCS stock opened at $34.95 on Friday. The firm has a market cap of $6.73 billion, a P/E ratio of 53.77, a P/E/G ratio of 17.21 and a beta of 0.86. Doximity, Inc. has a 1-year low of $22.91 and a 1-year high of $64.95. The business's 50 day moving average is $33.46 and its 200-day moving average is $33.20.
Doximity (NASDAQ:DOCS – Get Rating) last released its quarterly earnings results on Thursday, November 10th. The company reported $0.12 EPS for the quarter, hitting analysts' consensus estimates of $0.12. The business had revenue of $102.19 million for the quarter, compared to analyst estimates of $99.86 million. Doximity had a return on equity of 16.41% and a net margin of 36.70%. Sell-side analysts forecast that Doximity, Inc. will post 0.52 EPS for the current year.Analyst Upgrades and Downgrades
DOCS has been the subject of several research reports. Piper Sandler reduced their price objective on Doximity from $39.00 to $35.00 in a research note on Friday, November 11th. BTIG Research assumed coverage on Doximity in a report on Thursday, October 13th. They set a "neutral" rating on the stock. Evercore ISI lifted their price objective on Doximity from $28.00 to $32.00 in a research note on Friday, November 11th. Morgan Stanley lowered Doximity from an "equal weight" rating to an "underweight" rating and dropped their price objective for the stock from $32.00 to $29.00 in a research note on Friday, January 6th. Finally, Wells Fargo & Company lifted their target price on Doximity from $38.00 to $44.00 and gave the stock an "overweight" rating in a research report on Friday, November 11th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $41.40.
Doximity Company Profile
(Get Rating)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Get a free copy of the StockNews.com research report on Doximity (DOCS)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Get Rating).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.